SURMODICS INC — Director's Dealing 2018

May 23, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2018-05-21

Reporting Person: BEDOYA JOSE H (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-05-21	Common Stock	M	11450	$12.40	Acquired	30889	Direct
2018-05-21	Common Stock	S	11450	$48.1737	Disposed	19439	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-05-21	Stock Option (right to buy)	$12.40	M	11450	Disposed	2018-11-30	Common Stock (11450)	Direct

Footnotes

F1: Reflects the weighted average price of 11,450 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on May 21, 2018 with sale prices ranging from $47.80 to $48.50 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2: The amount beneficially owned includes 8,684 restricted stock units (RSUs) that vest on service-based vesting dates and 8,430 DSUs that are vested upon issuance, each of which will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting person's service as a director ends.

F3: Fully vested.